secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0001837607-24-000085
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma posts new corporate presentation highlighting prabotulinumtoxinA biosimilar
--------------------------------------------------------------------------------

- Corporate presentation posted on IR site on October 7, 2024, used for investor meetings.
- Slide deck focuses on prabotulinumtoxinA as a potential biosimilar for therapeutic indications.
- No financial results, guidance, or material corporate events disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760724000085/0001837607-24-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760724000085/aeon-20241007x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-24-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer